Scientific generalization of the international framework for the development of the extemporaneous compounding of medicines
Keywords:magistral formula, extemporaneous compounding, medicine, Formulary, Pharmacopoeia, scientific journal, database
Aim. To generalize the international principles of the organization of the extemporaneous compounding for the purpose of its development in Ukraine.
Materials and methods. The works of domestic and foreign authors, international professional web sites, databases, national formularies, methods of analysis, systematization, generalization, analytical and review were used.
Results. The international experience has shown that the extemporaneous compounding of medicines is used and developed in all developed countries of the world, while in Ukraine this area of pharmacy regresses. In the conditions of modern scientific and technological progress the key to the safe, effective, rational, affordable pharmacotherapy is continuous professional development and access to relevant information. Professional organizations have been created for continuous training in extemporaneous compounding in other countries. All over the world, pharmaceutical information sources are represented by official formularies and pharmacopoeias, scientific journals and online databases. In Ukraine, the main reference sources for the magistral formula are the information letters of the Ministry of Health and 2 professional journals.
Conclusions. Since there is no professional organization in Ukraine (such as foreign ones) that would be engaged in the development of extemporaneous compounding, medical prescriptions have remained almost unchanged for a decade. In this regard, specialists of compounding pharmacies, as well as doctors, can use data from reference sources of information from international organizations of other countries to increase their level of competence. The analysis conducted has shown that most countries of the world widely use the pharmacoeconomic principles for selecting magistral formulas for extemporaneous medicines. The results of the analysis give grounds to develop domestic compounding pharmacies in order to provide the availability, rationality and safety of patients’ pharmacotherapy on the way of European integration
Dooms, M., Carvalho, M. (2018). Compounded medication for patients with rare diseases. Orphanet
Journal of Rare Diseases, 13 (1), 1. doi:10.1186/s13023-017-0741-y.
Chernykh, V., Polovko, N. (2017). Realities and Prospects for Extemporal Drug Production in Ukraine.
Modern advances in pharmaceutical technology and biotechnology. (pp 3-7.). Kharkiv: NUPh.
Korytniuk, R. S., Hudz, N. I., Fetko, M. M., Vyshnevska, L. I., Heorhiievskyi, H. V. (2015). Farmakom, 3 (4), 73-77.
Soloviov, O. S. Tykhonov, O. I., Yarnykh, T. H., Hudzenko, O. P., Rukhmakova, O. A. (2014). Pharm. Journal, 1, 3-21.
Order of the Ministry of Health of Ukraine of 18.04.2019 No. 892. “About the approvement of the eleventh issue of the State Formulary of Medicines and providing its availability”. moz.gov.ua. Available
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).